Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meta Roestenberg

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Vaccines|January 24, 2025
Safety, Tolerability, and Immunogenicity of the Invaplex<sub>AR-Detox</sub><i>Shigella</i> Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical TrialGeert V T Roozen, Nsofwa Sukwa, Masuzyo Chirwa, et al.
The Lancet. Microbe|December 2, 2023
Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trialMarie-Astrid Hoogerwerf, Jacqueline J Janse, Vincent P Kuiper, et al.
ACS Infectious Diseases|April 21, 2023
Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022Nicola Caldwell, Rana Afshar, Beatriz Baragaña, et al.
Journal of Travel Medicine|April 21, 2020
Antigen-based diagnosis of Schistosoma infection in travellers: a prospective studyMiriam Casacuberta-Partal, Jacqueline J Janse, Roos van Schuijlenburg, et al.
The Lancet. Infectious Diseases|June 30, 2020
Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasisAbena S Amoah, Pytsje T Hoekstra, Miriam Casacuberta-Partal, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2024
How to develop a controlled human infection model for Clostridioides difficileAnnefleur D O Hensen, Maria J G T Vehreschild, Dale N Gerding, et al.
Science (New York, N.Y.)|July 11, 2020
Unnecessary hesitancy on human vaccine tests-ResponseSeema K Shah, Franklin G Miller, Thomas C Darton, et al.
Science (New York, N.Y.)|May 9, 2020
Ethics of controlled human infection to address COVID-19Seema K Shah, Franklin G Miller, Thomas C Darton, et al.
Plos One|December 19, 2008
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02Meta Roestenberg, Ed Remarque, Erik de Jonge, et al.
The Journal of Infectious Diseases|July 10, 2020
A Randomized Controlled Trial to Investigate Safety and Variability of Egg Excretion After Repeated Controlled Human Hookworm InfectionMarie-Astrid Hoogerwerf, Jan Pieter R Koopman, Jacqueline J Janse, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Vaccines|January 24, 2025
Safety, Tolerability, and Immunogenicity of the Invaplex<sub>AR-Detox</sub><i>Shigella</i> Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical TrialGeert V T Roozen, Nsofwa Sukwa, Masuzyo Chirwa, et al.
The Lancet. Microbe|December 2, 2023
Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trialMarie-Astrid Hoogerwerf, Jacqueline J Janse, Vincent P Kuiper, et al.
ACS Infectious Diseases|April 21, 2023
Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022Nicola Caldwell, Rana Afshar, Beatriz Baragaña, et al.
Journal of Travel Medicine|April 21, 2020
Antigen-based diagnosis of Schistosoma infection in travellers: a prospective studyMiriam Casacuberta-Partal, Jacqueline J Janse, Roos van Schuijlenburg, et al.
The Lancet. Infectious Diseases|June 30, 2020
Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasisAbena S Amoah, Pytsje T Hoekstra, Miriam Casacuberta-Partal, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2024
How to develop a controlled human infection model for Clostridioides difficileAnnefleur D O Hensen, Maria J G T Vehreschild, Dale N Gerding, et al.
Science (New York, N.Y.)|July 11, 2020
Unnecessary hesitancy on human vaccine tests-ResponseSeema K Shah, Franklin G Miller, Thomas C Darton, et al.
Science (New York, N.Y.)|May 9, 2020
Ethics of controlled human infection to address COVID-19Seema K Shah, Franklin G Miller, Thomas C Darton, et al.
Plos One|December 19, 2008
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02Meta Roestenberg, Ed Remarque, Erik de Jonge, et al.
The Journal of Infectious Diseases|July 10, 2020
A Randomized Controlled Trial to Investigate Safety and Variability of Egg Excretion After Repeated Controlled Human Hookworm InfectionMarie-Astrid Hoogerwerf, Jan Pieter R Koopman, Jacqueline J Janse, et al.
Pageof 13